-
公开(公告)号:WO2005058884A3
公开(公告)日:2005-06-30
申请号:PCT/US2004/041852
申请日:2004-12-14
Applicant: JAPAN TOBACCO INC. , INABA, Takashi , HAAS, Julia , SHIOZAKI, Makoto , LITTMAN, Nicole, M. , YASUE, Katsutaka , ANDREWS, Steven, W. , SAKAI, Atushi , FRYER, Andrew, M. , MATSUO, Takafumi , LAIRD, Ellen, R. , SUMA, Akira , SHINOZAKI, Yuichi , HORI, Yoshikazu , IMAI, Hiroto , NEGORO, Tamotsu
Inventor: INABA, Takashi , HAAS, Julia , SHIOZAKI, Makoto , LITTMAN, Nicole, M. , YASUE, Katsutaka , ANDREWS, Steven, W. , SAKAI, Atushi , FRYER, Andrew, M. , MATSUO, Takafumi , LAIRD, Ellen, R. , SUMA, Akira , SHINOZAKI, Yuichi , HORI, Yoshikazu , IMAI, Hiroto , NEGORO, Tamotsu
IPC: A61P19/02
Abstract: The present invention provides a compound having aggrecanase inhibitory activity and MMP-13 inhibitory activity, and useful as a therapeutic agent for osteoarthritis, rheumatoid arthritis and the like, more specifically, a cyclopropane compound of formula (1): wherein R 1 is - (CH 2 ) m -X- (CH 2 ) n -A 1 etc., wherein m and n are the same or different and each is 0 to 6, X is a single bond, etc. and A 1 is a substituted C 3-14 hydrocarbon ring group, etc.; R 2 and R 3 are the same or different and each is a hydrogen atom, -(CH 2 ) p -X 1 -(CH 2 ) q -A 2 , etc., wherein p and q are the same or different and each is 0 to 6, X 1 is a single bond, etc. and A 2 is an optionally substituted C 3-14 hydrocarbon ring group, etc.; R 4 is -C0 2 R 9 , etc., wherein R 9 is a hydrogen atom, etc.; and R 20 and R 21 are the same or different and each is a hydrogen atom, - (CH 2 ) m12- X 12- (CH 2 ) m12 -R 30 , etc., wherein m12 and m12 are the same or different and each is 0 to 6, X 12 is a single bond, etc. and R 30 is a hydrogen atom, etc.; or a prodrug thereof or a pharmaceutically acceptable salt thereof.
-
2.
公开(公告)号:WO2005058884A2
公开(公告)日:2005-06-30
申请号:PCT/US2004041852
申请日:2004-12-14
Applicant: JAPAN TOBACCO INC , INABA TAKASHI , HAAS JULIA , SHIOZAKI MAKOTO , LITTMAN NICOLE M , YASUE KATSUTAKA , ANDREWS STEVEN W , SAKAI ATUSHI , FRYER ANDREW M , MATSUO TAKAFUMI , LAIRD ELLEN R , SUMA AKIRA , SHINOZAKI YUICHI , HORI YOSHIKAZU , IMAI HIROTO , NEGORO TAMOTSU
Inventor: INABA TAKASHI , HAAS JULIA , SHIOZAKI MAKOTO , LITTMAN NICOLE M , YASUE KATSUTAKA , ANDREWS STEVEN W , SAKAI ATUSHI , FRYER ANDREW M , MATSUO TAKAFUMI , LAIRD ELLEN R , SUMA AKIRA , SHINOZAKI YUICHI , HORI YOSHIKAZU , IMAI HIROTO , NEGORO TAMOTSU
IPC: A61K31/18 , A61K31/381 , A61K31/496 , C07C311/13 , C07C311/20 , C07C311/22 , C07C311/29 , C07C311/36 , C07C311/46 , C07D205/04 , C07D207/08 , C07D207/48 , C07D209/44 , C07D211/14 , C07D211/58 , C07D211/96 , C07D213/18 , C07D213/30 , C07D213/65 , C07D213/71 , C07D213/74 , C07D213/81 , C07D213/82 , C07D217/08 , C07D217/16 , C07D231/12 , C07D233/54 , C07D237/12 , C07D239/22 , C07D241/04 , C07D241/38 , C07D243/08 , C07D257/04 , C07D261/08 , C07D265/30 , C07D271/06 , C07D271/10 , C07D271/107 , C07D277/20 , C07D277/26 , C07D277/36 , C07D277/82 , C07D295/26 , C07D307/79 , C07D307/81 , C07D307/91 , C07D333/06 , C07D333/18 , C07D333/34 , C07D333/36 , C07D333/38 , C07D333/62 , C07D401/04 , C07D403/04 , C07D409/04 , C07D409/12 , C07D409/14 , C07D413/04 , C07D417/04 , C07D417/12 , C07D419/04 , C07D419/14 , C07D471/04 , C07D487/04 , C07D513/04 , C07D513/06 , C07D409/00
CPC classification number: C07C311/29 , C07C311/13 , C07C311/20 , C07C311/22 , C07C311/46 , C07C2601/02 , C07C2601/14 , C07C2603/08 , C07C2603/18 , C07C2603/30 , C07D205/04 , C07D207/48 , C07D209/44 , C07D211/58 , C07D211/96 , C07D213/18 , C07D213/65 , C07D213/71 , C07D213/74 , C07D213/81 , C07D213/82 , C07D217/08 , C07D231/12 , C07D233/64 , C07D237/12 , C07D239/22 , C07D243/08 , C07D257/04 , C07D261/08 , C07D271/06 , C07D271/107 , C07D277/26 , C07D277/36 , C07D277/82 , C07D295/26 , C07D307/79 , C07D307/91 , C07D333/18 , C07D333/34 , C07D333/36 , C07D333/38 , C07D333/62 , C07D401/04 , C07D409/04 , C07D409/12 , C07D413/04 , C07D417/04 , C07D417/12 , C07D471/04 , C07D487/04 , C07D513/04
Abstract: The present invention provides a compound having aggrecanase inhibitory activity and MMP-13 inhibitory activity, and useful as a therapeutic agent for osteoarthritis, rheumatoid arthritis and the like, more specifically, a cyclopropane compound of formula (1): wherein R is - (CH2) m-X- (CH2)n-A etc., wherein m and n are the same or different and each is 0 to 6, X is a single bond, etc. and A is a substituted C3-14 hydrocarbon ring group, etc.; R and R are the same or different and each is a hydrogen atom, -(CH2)p-X1-(CH2)q-A , etc., wherein p and q are the same or different and each is 0 to 6, X1 is a single bond, etc. and A is an optionally substituted C3-14 hydrocarbon ring group, etc.; R is -C02R , etc., wherein R is a hydrogen atom, etc.; and R and R are the same or different and each is a hydrogen atom, - (CH2)m12-X12- (CH2)m12-R , etc., wherein m12 and m12 are the same or different and each is 0 to 6, X12 is a single bond, etc. and R is a hydrogen atom, etc.; or a prodrug thereof or a pharmaceutically acceptable salt thereof.
Abstract translation: 本发明提供具有聚集蛋白聚糖蛋白聚糖酶抑制活性和MMP-13抑制活性的化合物,可用作骨关节炎,类风湿性关节炎等的治疗剂,更具体地,可以使用式(1)的环丙烷化合物:其中R 1为 - (CH 2)m -X-(CH 2)n A 1等,其中m和n相同或不同,各自为0至6,X为单键等,A 1为取代的C 3 - 14烃环基等; R 2和R 3相同或不同,各自为氢原子, - (CH 2)p -X 1 - (CH 2)q A 2等,其中p和q相同或不同, 各自为0〜6,X1为单键等,A 2为任选取代的C3-14烃环基等。 R 4是-CO 2 R 9等,其中R 9是氢原子等; 和R 20和R 21相同或不同,各自为氢原子, - (CH 2)m 12 -X 12 - (CH 2)m 12 -R 30等,其中m12和m12相同 或不同,各为0〜6,X 12为单键等,R 30为氢原子等。 或其前药或其药学上可接受的盐。
-